scPharmaceuticals Inc., is a biopharmaceutical company known for its revolutionary drug delivery platforms focused on subcutaneous routes. It has built a reputation in the US market for developing transformative pharmaceutical products that enhance patients' care quality and improve health outcomes.
Operating within the biotechnology sector, scPharmaceuticals Inc. showcases an impressive repertoire of cutting-edge services. Notably, it is behind the innovative FUROSCIX, a pioneering treatment for heart failure patients. Although autonomously run, scPharmaceuticals is an integral part of the larger healthcare industry.
Add SCPH stock to your eToro watchlist today.